Detalhe da pesquisa
1.
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
Breast Cancer Res
; 26(1): 20, 2024 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297352
2.
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot.
Cancer
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662502
3.
The Growing Role of Digital Health Tools in the Care of Patients with Cancer: Current Use, Future Opportunities, and Barriers to Effective Implementation.
Curr Oncol Rep
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652424
4.
Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast.
Breast Cancer Res Treat
; 200(2): 217-224, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210429
5.
An open label phase II study of safety and clinical activity of naltrexone for treatment of hormone refractory metastatic breast cancer.
Invest New Drugs
; 41(1): 70-75, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441436
6.
Patient Satisfaction With a Multisite, Multiregional Remote Patient Monitoring Program for Acute and Chronic Condition Management: Survey-Based Analysis.
J Med Internet Res
; 25: e44528, 2023 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343182
7.
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study.
Breast Cancer Res Treat
; 196(1): 229-237, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045271
8.
Five-Year Cumulative Incidence of Axillary Web Syndrome and Comparison in Upper Extremity Movement, Function, Pain, and Lymphedema in Survivors of Breast Cancer With and Without Axillary Web Syndrome.
Arch Phys Med Rehabil
; 103(9): 1798-1806, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398047
9.
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.
Pharmacogenet Genomics
; 31(1): 1-9, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649577
10.
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).
Breast Cancer Res Treat
; 188(2): 477-487, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852121
11.
Adaptive Randomization of Neratinib in Early Breast Cancer.
N Engl J Med
; 375(1): 11-22, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406346
12.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
N Engl J Med
; 375(1): 23-34, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406347
13.
NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Breast Cancer Res
; 20(1): 105, 2018 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30180881
14.
Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer.
Breast Cancer Res Treat
; 168(3): 639-647, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29289986
15.
Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors.
J Natl Compr Canc Netw
; 16(5): 526-534, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29752327
16.
Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer.
Breast Cancer Res Treat
; 164(3): 515-525, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28493045
17.
A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.
Breast Cancer Res Treat
; 163(3): 535-544, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28324268
18.
Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.
Cancer
; 122(3): 378-85, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26512815
19.
Landscape of neoadjuvant therapy for breast cancer.
Ann Surg Oncol
; 22(5): 1408-15, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25727557
20.
Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early-stage breast cancer: A prospective trial.
Clin Cancer Res
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38752717